18 May 2013
Keywords: merck, co, announces, trade, name, mk-0431a, announced
Article | 11 December 2006
Merck & Co has announced the trademark Janumet for MK-0431A, the company's investigational oral medicine combining sitagliptin phosphate
with metformin ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 December 2006
17 May 2013
© 2013 thepharmaletter.com